Systemic Lupus Erythematosus Measures British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Measure (SLEDAI), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology-Damage Index (SLICC/ACR-DI; SDI) Rosalind Ramsey-Goldman 1 and David A. Isenberg 2 BRITISH ISLES LUPUS ASSESSMENT GROUP (BILAG) General Description Purpose. To assess lupus activity based upon premise of “intention to treat.” Content. Specific manifestations in 8 organs/systems. Developer/contact information. The BILAG Group: Current chair of the BILAG group is Professor Isenberg, Center for Rheumatology, The Middlesex Hospital, Arthur Stanley House, 40-50 Tottenham Street, London W1T 4NJ, UK. Versions. English only. Paper or computer version. Number of items in scale. 86. Subscales. Lupus activity is divided into 8 organs/systems, with varying numbers of items in each. Populations. Developmental/target. The measure was developed and validated specifically for patients with systemic lupus erythematosus (SLE). Other uses. None. WHO ICF Components. Not applicable. Administration Method. A rating completed by the doctor or as part of the British Lupus Integrated Program (BLIPs) software program. The computer version is available from Gordon Hamilton, E-mail: LIMATHON@aol.com. Training. Appreciation of the concept is needed. Some advice from a member of the BILAG or Systemic Lupus International Collaborations Clinics (SLICC) Group (current list is available from Professor Isenberg) is suggested; (Center for Rheumatology, The Middlesex Hospital, Arthur Stanley House, 40-50 Tottenham Street, London W1T 4 NJ, UK). Time to administer/complete. A complete history and physical examination is needed. To complete the form in an essentially well patient with a short history takes less than 5 minutes. For a complex patient not well known to the physician it can take up to 20 minutes. For most patients less than 5– 8 minutes. Equipment needed. None. Cost/availability. See Reference 1. No cost to use (unless the computerized version is needed, the cost then depends upon type of usage (commercial/academic). Dr. Ramsey-Goldman is supported by NIH/NIAMS P60- AR48098 and K24-AR02138, Arthritis Foundation Clinical Science Grant, Arthritis Foundation Greater Chicago Chap- ter, and Lupus Foundation of Illinois. Dr. Isenberg is cur- rently funded by a program grant from the Arthritis Re- search Campaign, UK. 1 Rosalind Ramsey-Goldman, MD, DrPH: Northwestern University, Feinberg School of Medicine, Chicago, Illinois; 2 David A. Isenberg, MD, FRCP: University College London, UK. Address correspondence to Rosalind Ramsey-Goldman, MD, DrPH, Professor of Medicine, Northwestern University, Feinberg School of Medicine, Arthritis, Ward 3-315, 303 E. Chicago Avenue, Chicago, IL 60611. E-mail: rgramsey@ northwestern.edu. Submitted April 23, 2003; accepted April 24, 2003. Arthritis & Rheumatism (Arthritis Care & Research) Vol. 49, No. 5S, October 15, 2003, pp S225–S233 DOI 10.1002/art.11402 © 2003, American College of Rheumatology DISEASE-SPECIFIC MEASURES S225